DCA seizes syrup stocks over misleading fever cure claim

Officials from the Telangana Drugs Control Administration (DCA) have seized stocks of a syrup marketed as a cure for ‘all types of fevers’, citing violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During a raid conducted on May 14 at a medical store in Adilabad, the DCA officers found the product, ‘Herbal Fever Guard Syrup’ being sold with a label that falsely claimed it could treat all types of fevers. The medicine is manufactured and marketed by International Herbal Corporation Private Limited, based in Haridwar, Uttarakhand, said a release.

Authorities said the product’s label amounts to a misleading advertisement, which is prohibited under the 1954 Act. The law explicitly bans advertisements that promote medicines as treatments for certain diseases and conditions, including fevers in general. As per the Act, no person is allowed to participate in the publication or circulation of such advertisements.

Stocks of the syrup were seized on the spot, and further investigation is underway, the release stated.

Related Posts

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

STF busts fake meds racket spread across 6 states

Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug